Kyowa Kirin (OTCMKTS:KYKOF) Shares Up 21.2% – Here’s What Happened

Shares of Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) traded up 21.2% during trading on Monday . The stock traded as high as $15.05 and last traded at $15.05. 900 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 2,050 shares. The stock had previously closed at $12.42.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group downgraded shares of Kyowa Kirin to a “sell” rating in a research report on Tuesday, December 16th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Kyowa Kirin Stock Performance

The business’s 50 day simple moving average is $14.14 and its 200-day simple moving average is $15.32.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.

The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.